244 related articles for article (PubMed ID: 31748470)
21. Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit.
Wiederkehr JC; Kondos GT; Pollak R
Transplantation; 1990 Sep; 50(3):466-71. PubMed ID: 2144923
[TBL] [Abstract][Full Text] [Related]
22. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Ooshima A; Yoshida H; Kawai C
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5928-31. PubMed ID: 3475709
[TBL] [Abstract][Full Text] [Related]
23. Notes on the breeding of the WHHL rabbit: an animal model of familial hypercholesterolemia.
Phelan JP; Van Lenten BJ; Fogelman AM; Kean C; Haberland ME; Edwards PA
J Lipid Res; 1985 Jun; 26(6):776-8. PubMed ID: 4031657
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo gene therapy of familial hypercholesterolemia.
Wilson JM; Grossman M; Raper SE; Baker JR; Newton RS; Thoene JG
Hum Gene Ther; 1992 Apr; 3(2):179-222. PubMed ID: 1391038
[TBL] [Abstract][Full Text] [Related]
25. Cardiac function of WHHL rabbit, an animal model of familial hypercholesterolemia.
Saku K; Fujino M; Yamamoto K; Ying H; Tashiro N; Harada R; Okabe M; Arakawa K
Artery; 1990; 17(5):271-80. PubMed ID: 2396901
[TBL] [Abstract][Full Text] [Related]
26. beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits.
Holvoet P; Collen D
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2376-82. PubMed ID: 9409204
[TBL] [Abstract][Full Text] [Related]
27. A comparative study on serum lipids and atherosclerotic plaque formation in diet-induced and familial hypercholesterolemia in rabbits, and the effect of partial ileal bypass.
van Niekerk JL; Demacker PN; Hendriks T; de Boer HH
Artery; 1985; 12(4):263-76. PubMed ID: 4074136
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia.
Shiomi M; Takeda H; Irino Y; Kimura N; Yamada S; Kuniyoshi N; Kikumori A; Koike Y; Koike T; Yoshida M; Izumi Y; Shinohara M; Bamba T; Ishida T
Atherosclerosis; 2019 May; 284():18-23. PubMed ID: 30870703
[TBL] [Abstract][Full Text] [Related]
29. Ischemic heart disease in the WHHL rabbit: a model for myocardial injury in genetically hyperlipidemic animals.
Hatanaka K; Ito T; Shiomi M; Yamamoto A; Watanabe Y
Am Heart J; 1987 Feb; 113(2 Pt 1):280-8. PubMed ID: 3812179
[TBL] [Abstract][Full Text] [Related]
30. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
Miname MH; Bittencourt MS; Nasir K; Santos RD
Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
[TBL] [Abstract][Full Text] [Related]
31. Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia.
Kita T; Brown MS; Watanabe Y; Goldstein JL
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2268-72. PubMed ID: 6264472
[TBL] [Abstract][Full Text] [Related]
32. HMG-CoA reductase inhibitor augments the serum total cholesterol-lowering effect of human adipose tissue-derived multilineage progenitor cells in hyperlipidemic homozygous Watanabe rabbits.
Saga A; Okura H; Soeda M; Tani J; Fumimoto Y; Komoda H; Moriyama M; Moriyama H; Yamashita S; Ichinose A; Daimon T; Hayakawa T; Matsuyama A
Biochem Biophys Res Commun; 2011 Aug; 412(1):50-4. PubMed ID: 21806964
[TBL] [Abstract][Full Text] [Related]
33. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia.
Tanzawa K; Shimada Y; Kuroda M; Tsujita Y; Arai M; Watanabe H
FEBS Lett; 1980 Aug; 118(1):81-4. PubMed ID: 7409195
[No Abstract] [Full Text] [Related]
34. Hypercholesterolemia and atherosclerosis in the WHHL rabbit, an animal model of familial hypercholesterolemia.
Shiomi M; Ito T; Watanabe Y
Prog Clin Biol Res; 1987; 229():35-40. PubMed ID: 3601993
[No Abstract] [Full Text] [Related]
35. Effects of atherosclerosis on mean and daily variation of arterial pressure in conscious WHHL rabbits.
Katsuda S; Hosomi H; Shiomi M; Watanabe Y
J Vet Med Sci; 1992 Aug; 54(4):669-73. PubMed ID: 1391177
[TBL] [Abstract][Full Text] [Related]
36. Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia.
Tilton GD; Buja LM; Bilheimer DW; Apprill P; Ashton J; McNatt J; Kita T; Willerson JT
J Am Coll Cardiol; 1985 Jul; 6(1):141-4. PubMed ID: 4008771
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of HDL-apo A-I in the WHHL rabbit, an animal model of familial hypercholesterolemia.
Saku K; Yamamoto K; Sakai T; Yanagida T; Hidaka K; Sasaki J; Arakawa K
Atherosclerosis; 1989 Oct; 79(2-3):225-30. PubMed ID: 2597230
[TBL] [Abstract][Full Text] [Related]
38. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits.
Shiomi M; Ito T; Tsukada T; Tsujita Y; Horikoshi H
Atherosclerosis; 1999 Feb; 142(2):345-53. PubMed ID: 10030386
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis.
Atkinson JB; Hoover RL; Berry KK; Swift LL
Atherosclerosis; 1989 Aug; 78(2-3):123-36. PubMed ID: 2783197
[TBL] [Abstract][Full Text] [Related]
40. Lipid Profiling of Serum and Lipoprotein Fractions in Response to Pitavastatin Using an Animal Model of Familial Hypercholesterolemia.
Takeda H; Izumi Y; Tamura S; Koike T; Koike Y; Shiomi M; Bamba T
J Proteome Res; 2020 Mar; 19(3):1100-1108. PubMed ID: 31965805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
